NCT07531589

Brief Summary

The goal of this mixed method study is to evaluate whether the volunteer-led Cognitive Stimulation Therapy (CST) under the BrainLive Connect programme is effective for improving cognitive function and quality of life of people living with dementia (PLwD). The main question it aims to answer are:

  • Do PLwD receiving the BrainLive Connect service show better cognitive function and quality of life than those receiving usual care? Researchers will compare BrainLive Connect service to usual care to see whether the intervention leads to better outcomes. Participants will:
  • Receive either 7 weeks of BrainLive Connect sessions delivered by trained volunteers or continue receiving usual care.
  • Be assessed at baseline (T0), post-intervention (7 weeks; T1), and 1 month follow up (11 weeks; T2).
  • Take part in semi-strucutred interviews post-intervention to provide feedback on implementation and areas for improvement.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
520

participants targeted

Target at P75+ for not_applicable

Timeline
19mo left

Started Apr 2026

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 8, 2026

Completed
7 days until next milestone

First Posted

Study publicly available on registry

April 15, 2026

Completed
6 days until next milestone

Study Start

First participant enrolled

April 21, 2026

Expected
1.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 10, 2027

Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 10, 2027

Last Updated

April 15, 2026

Status Verified

March 1, 2026

Enrollment Period

1.6 years

First QC Date

April 8, 2026

Last Update Submit

April 8, 2026

Conditions

Keywords

DementiaCognitive Stimulation TherapyVolunteer-led interventionQuality of lifeCognitive functionBrainLive ConnectCare burden

Outcome Measures

Primary Outcomes (2)

  • The Alzheimer's Disease Assessment Scale-Cognitive Subscale (ADAS-Cog)

    Possible range: 0 -70, with higher scores indicate more impairment

    Intake (T0), a 7-week follow-up (T1), and a one-month follow-up (T2)

  • Quality of Life-Alzheimer's Disease (QoL-AD)

    Possible range: 13 - 52, with higher scores indicate better quality of life

    Intake (T0), a 7-week follow-up (T1), and a one-month follow-up (T2)

Secondary Outcomes (7)

  • Neuropsychiatric Inventory Questionnaire (NPIQ)

    Intake (T0), a 7-week follow-up (T1), and a one-month follow-up (T2)

  • Social functioning in Dementia Scale (HKSF-DEM: carer rating)

    Intake (T0), a 7-week follow-up (T1), and a one-month follow-up (T2)

  • Care burden (Zarit Burden Interview short version, 12-item)

    Intake (T0), a 7-week follow-up (T1), and a one-month follow-up (T2)

  • The Lawton Instrumental Activities of Daily Living (IADL)

    Intake (T0), a 7-week follow-up (T1), and a one-month follow-up (T2)

  • Preference for ageing-in place (self-developed scale)

    Intake (T0), a 7-week follow-up (T1), and a one-month follow-up (T2)

  • +2 more secondary outcomes

Study Arms (2)

Non-professional delivered CST

EXPERIMENTAL

Participants will received 14-session Cognitive Stimulation Therapy (CST) delivered by trained volunteers; two sessions per week; for 7 weeks

Behavioral: Cognitive Stimulation Therapy (CST)

Usual social care

ACTIVE COMPARATOR

Participants will receive usual social care and support provided by elderly care service units operated by non-governmental organisations, including but not limited to care services, psychosocial intervention, and social activites.

Other: Usual Care

Interventions

CST has been recognized as an effective and cost-effective intervention for individuals with mild to moderate dementia, leading to improvements in cognition and quality of life. CST is one of the few non-pharmacological interventions recommended by the National Institute for Health and Care Excellence (NICE) in their clinical guideline on dementia, as it has comparable efficacy to anti-dementia drugs. Exercise-enhanced CST is characterised by adding physical exercise into the original group CST protocol. Home2Community CST is characterized by a gradual shift of its intervention site from the participant's home to public space in their neighbourhood and then further to centre-based settings. Living CST is characterised by transferring CST into real life settings to maximise its benefits in daily functioning for independent living.

Non-professional delivered CST

Usual care and support service for people living with dementia in community, including but not limited to, care service, psychosocial intervention (but not CST), and social activities.

Usual social care

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • PLwD: Hong Kong residents, mild to moderate dementia, either having i) a formal diagnosis, or 2) suspected dementia reported by care professionals and screened by Montreal Cognitive Assessment (MoCA).
  • Family carers: self-identified as the primary carer of the PLwD.

You may not qualify if:

  • Unable to communicate and participate in interviews/training/intervention due to hearing impairment, visual impairment, or other conditions.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

The University of Hong Kong

Hong Kong, Hong Kong

RECRUITING

Related Publications (7)

  • Groot C, Hooghiemstra AM, Raijmakers PG, van Berckel BN, Scheltens P, Scherder EJ, van der Flier WM, Ossenkoppele R. The effect of physical activity on cognitive function in patients with dementia: A meta-analysis of randomized control trials. Ageing Res Rev. 2016 Jan;25:13-23. doi: 10.1016/j.arr.2015.11.005. Epub 2015 Nov 28.

    PMID: 26607411BACKGROUND
  • Knapp M, Bauer A, Wittenberg R, Comas-Herrera A, Cyhlarova E, Hu B, Jagger C, Kingston A, Patel A, Spector A, Wessel A, Wong G. What are the current and projected future cost and health-related quality of life implications of scaling up cognitive stimulation therapy? Int J Geriatr Psychiatry. 2022 Jan;37(1). doi: 10.1002/gps.5633. Epub 2021 Oct 15.

    PMID: 34613622BACKGROUND
  • Knapp M, Thorgrimsen L, Patel A, Spector A, Hallam A, Woods B, Orrell M. Cognitive stimulation therapy for people with dementia: cost-effectiveness analysis. Br J Psychiatry. 2006 Jun;188:574-80. doi: 10.1192/bjp.bp.105.010561.

    PMID: 16738349BACKGROUND
  • Dementia: Assessment, management and support for people living with dementia and their carers. London: National Institute for Health and Care Excellence (NICE); 2018 Jun. Available from http://www.ncbi.nlm.nih.gov/books/NBK513207/

    PMID: 30011160BACKGROUND
  • Ryan S, Brady O. Cognitive stimulation and activities of daily living for individuals with mild-to-moderate dementia: A scoping review. Br J Occup Ther. 2023 Aug;86(8):540-559. doi: 10.1177/03080226231156517. Epub 2023 Mar 15.

    PMID: 40337614BACKGROUND
  • Toh HM, Ghazali SE, Subramaniam P. The Acceptability and Usefulness of Cognitive Stimulation Therapy for Older Adults with Dementia: A Narrative Review. Int J Alzheimers Dis. 2016;2016:5131570. doi: 10.1155/2016/5131570. Epub 2016 Jul 11.

    PMID: 27478677BACKGROUND
  • Desai R, Leung WG, Fearn C, John A, Stott J, Spector A. Effectiveness of Cognitive Stimulation Therapy (CST) for mild to moderate dementia: A systematic literature review and meta-analysis of randomised control trials using the original CST protocol. Ageing Res Rev. 2024 Jun;97:102312. doi: 10.1016/j.arr.2024.102312. Epub 2024 Apr 16.

    PMID: 38636561BACKGROUND

MeSH Terms

Conditions

DementiaCaregiver Burden

Condition Hierarchy (Ancestors)

Brain DiseasesCentral Nervous System DiseasesNervous System DiseasesNeurocognitive DisordersMental DisordersStress, PsychologicalBehavioral SymptomsBehavior

Central Study Contacts

JACKY C.P. CHOY, PhD

CONTACT

Shiyu LU, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Research Assistant Professor

Study Record Dates

First Submitted

April 8, 2026

First Posted

April 15, 2026

Study Start (Estimated)

April 21, 2026

Primary Completion (Estimated)

November 10, 2027

Study Completion (Estimated)

November 10, 2027

Last Updated

April 15, 2026

Record last verified: 2026-03

Data Sharing

IPD Sharing
Will share

Anonymised data will be available upon request.

Shared Documents
STUDY PROTOCOL, SAP, ICF, CSR, ANALYTIC CODE
Time Frame
Anonymised data data will be available after the first manuscript using the study data is published.
Access Criteria
Anonymised data will be available upon request.

Locations